Drug Database
Back to search

Italy· 025462021

JUMEX*25 cpr 10 mg

A selegiline product containing selegilina, registered in Italy by CHIESI ITALIA SpA, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC N04BD01

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedJUMEX*25 cpr 10 mgATCN04BD01REGISTER NO.025462021PACKS LISTED1CHECKEDJune 4, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about selegilinaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Selegiline is registered in 14 of 19 countries.

Countries holding a registration under ATC N04BD01 (selegiline), each read from that country’s own register.

  • This record: Italy
  • 8 of them publish a price we can compare per daily dose
Search selegiline products by name

Selegiline · ATC N04BD01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of selegiline costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.24 in Italy to $0.62 in France — a ×2.5 gap.

  • Italy: $0.24 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Selegiline · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • FR France$0.62
  • IT Italy$0.24
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Active substance
Selegilina
Manufacturer
CHIESI ITALIA SpA
Country
Italy (IT)
ATC code
N04BD01
ATC class
Selegiline
Defined daily dose
5 mg, O
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    025462021
    JUMEX*25 cpr 10 mg
    EUR 15.99

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

187 interactions on record for selegiline.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check selegiline against other medicinesHow interaction checks work

Selegiline · interactions on record

187 records

  • 35 severe
  • 115 moderate
  • 1 minor
  • 21 info

Most severe, free to view

  • IsomethepteneA03AX10severe
  • OpiumA07DA02severe
  • PhentermineA08AA01severe
  • FenfluramineA08AA02severe

15 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Selegiline in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All selegiline products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Belgium · Eldepryl
  • Bulgaria · Jamax, Селегос
  • Cyprus · Selegos, Selex
  • Germany · Selegilin Neuraxpharm
  • Denmark · Eldepryl
  • Spain · Plurimen
  • Finland · Eldepryl
  • France · Deprenyl
  • United Kingdom (Northern Ireland) · Eldepryl, Selegiline Hydrochloride Activase Pharmaceuticals
  • Greece · Feliselin
  • Ireland · Eldepryl
  • Luxembourg · Eldepryl
  • Latvia · Eldepryl
  • Norway · Eldepryl
  • Poland · Selgres
  • Portugal · Selegilina Generis
  • Romania · Selegos
  • Sweden · Eldepryl

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dffc95fa-a175-431e-a178-a9dee122b2b7
GET /v1/drugs/dffc95fa-a175-431e-a178-a9dee122b2b7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 15.99,
  "source": "aifa",
  "currency": "EUR",
  "strength": "SELEGILINA 10MG 25 UNITA' USO ORALE",
  "substance": "Selegilina",
  "equivalence_group": "RSA",
  "transparency_flag": null
}
API referenceMCP serverPlans

See everything about selegiline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console